Ehlers-Danlos Syndromes (EDS) Panel
Use
This test is intended for individuals who have clinical or suspected diagnosis of Ehlers-Danlos syndromes (EDS) or a family history of EDS or related connective tissue disorders. The analysis provides comprehensive genetic profiling to aid in the diagnosis and management of EDS by covering a wide range of genes related to connective tissue disorders.
Special Instructions
Not provided.
Limitations
These genetic tests have not been cleared or approved by the US Food and Drug Administration. Results should be interpreted in conjunction with clinical findings and other diagnostic criteria. Variants of uncertain significance may be identified, and not all benign variants will be reported.
Methodology
NGS (CGP)
Biomarkers
Result Turnaround Time
7-16 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided